CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.300
+0.160 (3.86%)
At close: Jan 7, 2026, 4:00 PM EST
4.270
-0.030 (-0.70%)
After-hours: Jan 7, 2026, 5:56 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $728.57 million as of January 7, 2026. Its market cap has increased by 777.80% in one year.
Market Cap
728.57M
Enterprise Value
582.07M
1-Year Change
777.80%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $728.57M, an increase of 9,745.57%. That is a compound annual growth rate of 56.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 701.50M | -2.81% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.71B |
| Johnson & Johnson | 493.50B |
| AbbVie | 395.96B |
| UnitedHealth Group | 316.24B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.21B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |